Cargando…

Tumor regression in rectal cancer after intensified neoadjuvant chemoradiation: a morphometric and clinicopathological study

BACKGROUND: High interobserver variation is a well known drawback of conventional tumor regression grading, and reaching consensus among pathologists may require a considerable effort. Therefore, in this study, morphometry was tried to assess tumor regression, and its prognostic role was explored. M...

Descripción completa

Detalles Bibliográficos
Autores principales: Prall, Friedrich, Schmitt, Oliver, Schiffmann, Leif
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4415293/
https://www.ncbi.nlm.nih.gov/pubmed/25896880
http://dx.doi.org/10.1186/s12957-015-0572-z
_version_ 1782369048490672128
author Prall, Friedrich
Schmitt, Oliver
Schiffmann, Leif
author_facet Prall, Friedrich
Schmitt, Oliver
Schiffmann, Leif
author_sort Prall, Friedrich
collection PubMed
description BACKGROUND: High interobserver variation is a well known drawback of conventional tumor regression grading, and reaching consensus among pathologists may require a considerable effort. Therefore, in this study, morphometry was tried to assess tumor regression, and its prognostic role was explored. METHODS: Tumor regression was quantified by a point counting method to yield tumor area fraction (TAF) as an index of remaining vital tumor. RESULTS: In a series of 104 patients with clinically advanced rectal cancer treated with neoadjuvant radiochemotherapy, TAFs were distributed continuously towards complete regression which was observed in 8.7% of the cases. Plotting TAFs grouped by a conventional regression grading (Dworak’s) revealed considerable overlap between groups. In a control series of untreated cancers, only TAFs of cancers with an expansive invasive border were setoff clearly from TAFs obtained for the study cases, but TAFs of control cases with an infiltrative invasive border and mucinous carcinomas extended well into the range of TAFs recorded for regressing tumors. Locoregional recurrence (N = 10) was significantly associated with perineural tumor infiltration and capsule transgressing lymph node metastasis/tumor deposits but not with the degree of tumor regression. Overall survival was better for patients with major regressions (≤20th percentile by morphometry, or Dworak regression grade (DRG) 4/5), although statistical significance was not reached. CONCLUSIONS: Morphometry of tumor regression is feasible and explains why conventional regression grading is so difficult to perform. Assessment of tumor regression, by subjective grading or morphometry, does not appear to convey major prognostic information, at least not substantially beyond histopathological tumor staging. This observation discourages expending too much effort on developing this aspect of the pathomorphological workup of the resection specimens. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12957-015-0572-z) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4415293
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-44152932015-05-01 Tumor regression in rectal cancer after intensified neoadjuvant chemoradiation: a morphometric and clinicopathological study Prall, Friedrich Schmitt, Oliver Schiffmann, Leif World J Surg Oncol Research BACKGROUND: High interobserver variation is a well known drawback of conventional tumor regression grading, and reaching consensus among pathologists may require a considerable effort. Therefore, in this study, morphometry was tried to assess tumor regression, and its prognostic role was explored. METHODS: Tumor regression was quantified by a point counting method to yield tumor area fraction (TAF) as an index of remaining vital tumor. RESULTS: In a series of 104 patients with clinically advanced rectal cancer treated with neoadjuvant radiochemotherapy, TAFs were distributed continuously towards complete regression which was observed in 8.7% of the cases. Plotting TAFs grouped by a conventional regression grading (Dworak’s) revealed considerable overlap between groups. In a control series of untreated cancers, only TAFs of cancers with an expansive invasive border were setoff clearly from TAFs obtained for the study cases, but TAFs of control cases with an infiltrative invasive border and mucinous carcinomas extended well into the range of TAFs recorded for regressing tumors. Locoregional recurrence (N = 10) was significantly associated with perineural tumor infiltration and capsule transgressing lymph node metastasis/tumor deposits but not with the degree of tumor regression. Overall survival was better for patients with major regressions (≤20th percentile by morphometry, or Dworak regression grade (DRG) 4/5), although statistical significance was not reached. CONCLUSIONS: Morphometry of tumor regression is feasible and explains why conventional regression grading is so difficult to perform. Assessment of tumor regression, by subjective grading or morphometry, does not appear to convey major prognostic information, at least not substantially beyond histopathological tumor staging. This observation discourages expending too much effort on developing this aspect of the pathomorphological workup of the resection specimens. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12957-015-0572-z) contains supplementary material, which is available to authorized users. BioMed Central 2015-04-21 /pmc/articles/PMC4415293/ /pubmed/25896880 http://dx.doi.org/10.1186/s12957-015-0572-z Text en © Prall et al.; licensee BioMed Central. 2015 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Prall, Friedrich
Schmitt, Oliver
Schiffmann, Leif
Tumor regression in rectal cancer after intensified neoadjuvant chemoradiation: a morphometric and clinicopathological study
title Tumor regression in rectal cancer after intensified neoadjuvant chemoradiation: a morphometric and clinicopathological study
title_full Tumor regression in rectal cancer after intensified neoadjuvant chemoradiation: a morphometric and clinicopathological study
title_fullStr Tumor regression in rectal cancer after intensified neoadjuvant chemoradiation: a morphometric and clinicopathological study
title_full_unstemmed Tumor regression in rectal cancer after intensified neoadjuvant chemoradiation: a morphometric and clinicopathological study
title_short Tumor regression in rectal cancer after intensified neoadjuvant chemoradiation: a morphometric and clinicopathological study
title_sort tumor regression in rectal cancer after intensified neoadjuvant chemoradiation: a morphometric and clinicopathological study
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4415293/
https://www.ncbi.nlm.nih.gov/pubmed/25896880
http://dx.doi.org/10.1186/s12957-015-0572-z
work_keys_str_mv AT prallfriedrich tumorregressioninrectalcancerafterintensifiedneoadjuvantchemoradiationamorphometricandclinicopathologicalstudy
AT schmittoliver tumorregressioninrectalcancerafterintensifiedneoadjuvantchemoradiationamorphometricandclinicopathologicalstudy
AT schiffmannleif tumorregressioninrectalcancerafterintensifiedneoadjuvantchemoradiationamorphometricandclinicopathologicalstudy